Bayer PE Ratio 2006-2019 | BAYRY

Current and historical p/e ratio for Bayer (BAYRY) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Bayer PE ratio as of October 15, 2019 is 9.80.
Bayer PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
0.00 nan
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $67.293B $46.752B
Bayer AG, best known for its flagship product, Bayer Aspirin, produces a broad range of health care, crop protection, polymer, and chemical products that help diagnose and treat diseases, purify water, preserve local landmarks, protect crops, advance automobile safety and durability, and improve people's lives.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $344.992B 15.02
Roche Holding AG (RHHBY) Switzerland $246.683B 0.00
Merck (MRK) United States $216.838B 17.83
Pfizer (PFE) United States $200.777B 11.82
Novartis AG (NVS) Switzerland $196.934B 16.95
Novo Nordisk (NVO) Denmark $123.207B 21.77
AstraZeneca (AZN) United Kingdom $115.026B 22.25
Sanofi (SNY) France $112.411B 13.81
AbbVie (ABBV) United States $109.053B 8.74
GlaxoSmithKline (GSK) United Kingdom $105.181B 13.22
Eli Lilly (LLY) United States $104.170B 19.44
Bristol-Myers Squibb (BMY) United States $84.340B 11.96
H Lundbeck (HLUYY) Denmark $6.598B 9.52